Citation: | YE Qing, WANG SHuo, LIU Li-jiang, et al, . The study of specificity and stability of an anti-CD71 mouse/human chimeric antibody(Dd2C)-secreted transfectomas keeping in liquid nitrigen[J]. Cancer Research on Prevention and Treatment, 2003, 30(02): 95-97. DOI: 10.3971/j.issn.1000-8578.3145 |
[1] | HUANG Qing, XUE Chang, HU Sheng. Development on Cancer Therapeutic Drugs Approved by FDA in 2023[J]. Cancer Research on Prevention and Treatment, 2024, 51(7): 542-545. DOI: 10.3971/j.issn.1000-8578.2024.24.0040 |
[2] | ZHENG Yu, PAN Hongming. Progress of Targeted Therapy and Immunotherapy for Gastric Cancer[J]. Cancer Research on Prevention and Treatment, 2024, 51(4): 234-239. DOI: 10.3971/j.issn.1000-8578.2024.23.1257 |
[3] | CHEN Jiachen, WU Tingyu, XIA Weiliang. Relationship of EGFR-TKI Targeted Therapy and Pyroptosis in Non-small Cell Lung Cancer[J]. Cancer Research on Prevention and Treatment, 2023, 50(12): 1185-1190. DOI: 10.3971/j.issn.1000-8578.2023.23.0310 |
[4] | JI Xiaojun, ZHAO Tingli, MIAO Lei, SI Yaxuan, WU Jian, XU Dan. Progress in Development of Targeted Therapeutic Drugs for Acute Myeloid Leukemia[J]. Cancer Research on Prevention and Treatment, 2023, 50(4): 413-421. DOI: 10.3971/j.issn.1000-8578.2023.22.1056 |
[5] | LIU Shanting, QIN Jiali, FAN Jie. Dawn of Advanced Thyroid Cancer Therapy: Targeted Therapy and Immunotherapy[J]. Cancer Research on Prevention and Treatment, 2023, 50(1): 6-11. DOI: 10.3971/j.issn.1000-8578.2023.22.0869 |
[6] | YANG Junyuan, CAI Hongbing. Countermeasures and Mechanisms of Drug Resistance in Immunotherapy for Cervical Cancer[J]. Cancer Research on Prevention and Treatment, 2022, 49(9): 886-892. DOI: 10.3971/j.issn.1000-8578.2022.22.0162 |
[7] | ZHANG Jianning, LIU Congwei. Progress of Novel Treatment Options for Glioma[J]. Cancer Research on Prevention and Treatment, 2022, 49(6): 505-513. DOI: 10.3971/j.issn.1000-8578.2022.21.1514 |
[8] | YANG Changliang, ZHANG Shuang, LIU Jingjing, LI Shuang, CHENG Ying. New Immune Checkpoint: Advances in Immunotherapy for Malignant Tumors[J]. Cancer Research on Prevention and Treatment, 2018, 45(12): 1027-1035. DOI: 10.3971/j.issn.1000-8578.2018.18.0545 |
[9] | CHEN Rui, ZHAO Da, WANG Li'na. Mechanism and Strategies on Drug Resistance of Non-small Cell Lung Cancer to EGFR-TKI[J]. Cancer Research on Prevention and Treatment, 2017, 44(3): 225-230. DOI: 10.3971/j.issn.1000-8578.2017.03.014 |
[10] | FENG Chengjun, LIU Xiaoke, LI Xiaoyu, WANG Yongsheng. Progress of Zoledronic Acid Combined with Targeted or Immunomodulatory Drugs in Antitumor Research[J]. Cancer Research on Prevention and Treatment, 2015, 42(08): 843-847. DOI: 10.3971/j.issn.1000-8578.2015.08.020 |